(Q34276825)

1 August 2017

title

Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template (English)

1 reference

1 August 2017

1 reference

Ligong Liu

1

1 reference

1 August 2017

Caiping Li

2

1 reference

1 August 2017

Siska Cochran

3

1 reference

1 August 2017

Shane Jimmink

4

1 reference

1 August 2017

Vito Ferro

5

1 reference

1 August 2017

publication date

21 May 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

7

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

1267-1275

1 reference

Structure and biological interactions of heparin and heparan sulfate

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Heparin and heparan sulfate: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Heparin-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Insights into the role of heparan sulphate in fibroblast growth factor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Therapeutic value of glycosaminoglycans in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Roles of heparan-sulphate glycosaminoglycans in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

The role of heparan sulphate in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Cell surface heparan sulfate and its roles in assisting viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

The role of fibroblast growth factors in tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Tumor vasculature as target for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Identification of novel inhibitors of fibroblast growth factor (FGF-2) binding to heparin and endothelial cell survival from a structurally diverse carbohybrid library

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Fibroblast growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Synthesis and anti-HIV activity of nonatyrosine N- and O1-9-decasulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Synthesis and chain length-anti-HIV activity relationship of fully N- and O-sulfated homooligomers of tyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Heparin/heparan sulphate-based drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Use of sulfated linked cyclitols as heparan sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Cu-catalyzed azide-alkyne cycloaddition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

The growing impact of click chemistry on drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

CuI-Catalyzed Alkyne-Azide “Click” Cycloadditions from a Mechanistic and Synthetic Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Synthesis and cytotoxicities of mannose conjugated S-nitroso-N-acetylpenicillamine (SNAP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Validation of molecular docking calculations involving FGF-1 and FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Structure of a heparin-linked biologically active dimer of fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Application of copper(I)-catalysed azide/alkyne cycloaddition (CuAAC) ‘click chemistry’ in carbohydrate drug and neoglycopolymer synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Poly(N-acryl amino acids): A New Class of Biologically Active Polyanions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

inferred from DOI database lookup

7 January 2021

based on heuristic

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

inferred from DOI database lookup

7 January 2021

based on heuristic

Preparation and anticoagulant activity of the phosphosulfomannan PI-88

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200151

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201200151

1 reference

1 August 2017

1 reference